Latest News about FDA
Recent news which mentions FDA
FDA Panel Rejects Lexicon's Zynquista For Type 1 Diabetes
November 01, 2024
From Benzinga
From Benzinga
FDA Approval Of Orlynvah For Urinary Tract Infections Marks Milestone For Iterum, Paves Way For New Strategic Partnerships
October 28, 2024
From Benzinga
From Reefer Madness To Regulatory Madness: The FDA's Impact On The U.S. Hemp Industry
October 28, 2024
From Benzinga
EXCLUSIVE: Nano-Cap NeuroSense Schedules FDA Meeting To Advance Lead Program And Marketing Application Submission
October 28, 2024
From Benzinga
Trump Says Robert Kennedy Jr. Can Run Wild On Health And Food: 'I'm Going To Let Him Go Wild On The Medicines'
October 27, 2024
From Benzinga
Hologic Recalls Soft Tissue Marker Device BioZorb, FDA Issues Warning After Almost 400 Complaints
October 25, 2024
From Benzinga
McDonald's Rivals Burger King, Yum Brands Remove Onions From Menus Amid Quarter-Pounder E.Coli Scare
October 24, 2024
From Benzinga
FDA Launches Investigation Into McDonald's Supplier Taylor Farms Following E. Coli Outbreak
October 24, 2024
From Benzinga
$8B Market On The Brink: Texas Senator Calls It 'Uncontrollable,' Proposes Erasing Hemp
October 24, 2024
From Benzinga
JD Vance Pushes Debunked Claim Of Fentanyl-Laced Marijuana Despite New Harvard-Led Study Findings
October 24, 2024
Tickers
NEWS
From Benzinga
Penny Stock DBV Technologies Advances Viaskin Peanut Allergy Patch With FDA Approval Pathway
October 23, 2024
From Benzinga
FDA Approves Pfizer's Respiratory Syncytial Virus Vaccine Abrysvo For Adults Below 60 Years
October 23, 2024
From Benzinga
With FDA Approval iRhythm May Be Able To Lift Regulatory Overhang, Investor Skepticism, Analyst Says
October 22, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.